This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Illumina Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dale Weekes: Innovator in Sequencing Reagents
Introduction
Dale Weekes is a notable inventor based in Haverhill, GB. He has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods for sequencing reagents. His innovative work has led to the filing of a patent that showcases his expertise and creativity.
Latest Patents
Dale Weekes holds a patent for "Compositions, methods, kits, cartridges, and systems for sequencing reagents." This patent describes a composition that includes one or more modified nucleotides, which consist of a purine or pyrimidine base and a sugar moiety with a 3'-hydroxy blocking group, along with a radical scavenger. The composition is lyophilised, enhancing its stability and usability. Additionally, the patent outlines methods for rehydration of the compositions and includes kits and cartridges that incorporate these innovative compositions.
Career Highlights
Dale Weekes is currently associated with Illumina Corporation, a leading company in the field of genomics. His work at Illumina has allowed him to contribute to advancements in sequencing technologies, which are crucial for various applications in research and medicine. His patent reflects his commitment to improving the efficiency and effectiveness of sequencing processes.
Collaborations
Dale has collaborated with talented individuals such as Karen Goh and Dorry Poa. These collaborations have fostered a creative environment that encourages innovation and the development of cutting-edge technologies.
Conclusion
Dale Weekes is a prominent inventor whose work in sequencing reagents has made a significant impact in biotechnology. His patent and contributions at Illumina Corporation highlight his dedication to advancing the field. His innovative spirit continues to inspire others in the industry.